Ion-coupled transfersome complexes for enhanced transdermal NAD+ repletion and mitigation of cellular senescence signatures
Source abstract
Abstract
Nicotinamide adenine dinucleotide (NAD + ) is a pivotal coenzyme whose decline drives mitochondrial dysfunction and senescence. However, NAD + delivery to skin is limited by poor stability and tissue accessibility. Here, we develop an ion-coupled NAD + transfersome (ICoN) that stabilizes NAD + and enables efficient, non-invasive transdermal delivery. ICoN restores intracellular NAD + levels and reverses transcriptomic programs associated with DNA damage, oxidative stress, and senescence in vitro . Functionally, ICoN promotes mitochondrial functional integrity and sustains proliferative and migratory competence under senescent and NAD + -depleted conditions. In ex vivo porcine and human skin explants, ICoN achieves superior intratissue NAD + penetration while attenuating senescent signatures compared with free NAD + or precursors. Integrated high-spatial-resolution transcriptomic profiling and bulk transcriptomic analyses of UV-stressed human skin reveal that ICoN mitigates histological disruption and senescence-associated transcriptional programs at the tissue level. Moreover, ICoN extends lifespan and enhances healthspan in C . elegans . These findings characterize ICoN as a transdermal NAD + delivery platform supporting localized NAD + restoration in the context of skin aging.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Sirtuins and Resveratrol in Medicine · Calcium signaling and nucleotide metabolism · Molecular Sensors and Ion Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. NAD(+) homeostasis in health and disease10.1038/s42255-019-0161-5 ↗
2. NAD(+) metabolism and its roles in cellular processes during ageing10.1038/s41580-020-00313-x ↗
3. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling10.1016/j.cell.2013.06.016 ↗
4. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation10.1038/s41590-018-0255-3 ↗
5. NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice10.1126/science.aaf2693 ↗
6. It takes two to tango: NAD(+) and sirtuins in aging/longevity control10.1038/npjamd.2016.17 ↗
7. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases10.2741/2909 ↗
8. Evolving concepts in NAD(+) metabolism10.1016/j.cmet.2021.04.003 ↗
9. Sirtuin evolution at the dawn of animal life10.1093/molbev/msac192 ↗
10. NAD(+) metabolism in cardiac health, aging, and disease10.1161/CIRCULATIONAHA.121.056589 ↗
11. Senescent cells promote tissue NAD(+) decline during ageing via the activation of CD38(+) macrophages10.1038/s42255-020-00305-3 ↗
12. Roles of NAD(+) in health and aging10.1101/cshperspect.a041193 ↗
13. Chronic inflammation and the hallmarks of aging10.1016/j.molmet.2023.101755 ↗
14. Role of NAD(+) in regulating cellular and metabolic signaling pathways10.1016/j.molmet.2021.101195 ↗
15. The role of PARP1 in neurodegenerative diseases and aging10.1111/febs.15716 ↗
16. ADP-ribosylation, a multifaceted modification: functions and mechanisms in aging and aging-related diseases10.1016/j.arr.2024.102347 ↗
17. NAD(+) precursors: a questionable redundancy10.3390/metabo12070630 ↗
18. Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes10.1089/ars.2017.7269 ↗
19. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity10.1038/nature07813 ↗
20. NAD(+) metabolism, stemness, the immune response, and cancer10.1038/s41392-020-00354-w ↗
21. Magnitude and significance of NAD turnover in human cell line D98/AH210.1038/259695a0 ↗
22. NAD world 3.0: the importance of the NMN transporter and eNAMPT in mammalian aging and longevity control10.1038/s41514-025-00192-6 ↗
23. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial10.1007/s11357-022-00705-1 ↗
24. Nicotinamide adenine dinucleotide is transported into mammalian mitochondria10.7554/eLife.33246 ↗
25. Quantitative analysis of NAD synthesis-breakdown fluxes10.1016/j.cmet.2018.03.018 ↗
26. NAD in skin: therapeutic approaches for niacin10.2174/138161209787185760 ↗
27. Advance and challenges in the treatment of skin diseases with the transdermal drug delivery system10.3390/pharmaceutics15082165 ↗
28. Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: a nanotechnological perspective10.1016/j.biopha.2022.112633 ↗
29. Cell-permeable nicotinamide adenine dinucleotides for exploration of cellular protein ADP-ribosylation
30. Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations10.1007/s00018-022-04499-5 ↗
31. Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia10.2741/2267 ↗
32. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation10.1126/scitranslmed.aaf5504 ↗
33. Retinal drug delivery using eyedrop preparations of poly-L-lysine-modified liposomes10.1016/j.ejpb.2012.10.014 ↗
34. NAD(+) and vascular dysfunction: from mechanisms to therapeutic opportunities10.12997/jla.2022.11.2.111 ↗
35. Green, multiple-ligand collector sodium myristoyl glutamate for flotation of smithsonite10.1016/j.apsusc.2024.159932 ↗
36. DNA lipoplex-based light-harvesting antennae10.1002/adfm.201700212 ↗
37. Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK110.1242/jcs.059246 ↗
38. Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease10.1038/s41514-025-00291-4 ↗
39. Photoaging: UV radiation-induced inflammation and immunosuppression accelerate the aging process in the skin10.1007/s00011-022-01598-8 ↗
40. Metabolic dysfunction in human skin: restoration of mitochondrial integrity and metabolic output by nicotinamide (niacinamide) in primary dermal fibroblasts from older aged donors10.1111/acel.13248 ↗
41. Age-related disruption of autophagy in dermal fibroblasts modulates extracellular matrix components10.1016/j.bbrc.2013.11.066 ↗
42. Investigate correlation between mechanical property and aging biomarker in passaged human dermal fibroblasts10.1002/jemt.22472 ↗
43. Advancements in skin-mediated drug delivery: mechanisms, techniques, and applications
44. Microbiota and maintenance of skin barrier function10.1126/science.abo0693 ↗
45. Skin barrier function: the interplay of physical, chemical, and immunologic properties10.3390/cells12232745 ↗
46. Accurate measurement of nicotinamide adenine dinucleotide (NAD(+)) with high-performance liquid chromatography10.1007/978-1-62703-637-5_14 ↗
47. Conjugation-free multilamellar protein-lipid hybrid vesicles for multifaceted immune responses10.1002/adhm.202101239 ↗
48. NAD+-associated-hyaluronic acid and poly(L-lysine) polyelectrolyte complexes: an evaluation of their potential for ocular drug delivery10.1016/j.ejpb.2023.10.004 ↗
49. RNA-mediated demixing transition of low-density condensates10.1038/s41467-023-38118-z ↗
50. MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiation10.1038/s43018-025-01038-6 ↗
51. A microfluidic device to fabricate one-step cell bead-laden hydrogel struts for tissue engineering
52. Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming10.1038/s42003-020-0922-4 ↗
53. A single-cell transcriptomic atlas of human skin aging10.1016/j.devcel.2020.11.002 ↗
54. A microbiota-derived metabolite, 3-phenyllactic acid, prolongs healthspan by enhancing mitochondrial function and stress resilience via SKN-1/ATFS-1 in C. elegans10.1038/s41467-024-55015-1 ↗